New Delhi, July 25 -- From India's drugmakers bracing for steep US tariffs under Donald Trump's latest plan, to a revamped core sector index reshaping recent growth trends, India strengthening its lead in Mint's Emerging Markets Tracker, rural households experiencing their weakest income momentum since September 2024, and domestic air passenger traffic slipping back into contraction after a brief rebound - here are this week's news in numbers.

US President Donald Trump's latest tariff plan has brought concerns over India's pharmaceutical exports. From 1 August, generic medicines will continue entering the US duty-free for two years, after which they will face a 100% tariff for a year before the levy doubles to 200%.

Generic drugs had es...